Modified polio vaccine extends lives in U.S. brain cancer study

ReutersNewsPublished: June 26, 2018
Published: June 26, 2018

More than one in five patients with an advanced brain cancer treated with a genetically modified polio vaccine were alive after three years, compared with just 4 percent who received standard treatment, according to U.S. researchers. Stuart McDill reports.

Be the first to suggest a tag